Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21630308

Download in:

View as

General Info

PMID
21630308